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Hemodynamic study of' hypotension during hemodialysis. Hemody-
namic parameters were investigated continuously during hemodialysis
by catheterization in 14 patients. Eight patients (group 1) exhibited a
sudden fall (30 mm Hg) in mean arterial pressure (MAP) while six
others (group 2) did not. In group 1, the following sequence of events
induced the hypotension: (1) hypovolemia caused by ultrafiltration; (2)
decrease in plasma osmolality which delayed the liquid transfer from
extravascular spaces to the vascular compartment and lead to a shift of
fluid in the opposite direction; (3) decrease in filling pressures; (4)
disequilibrium between the diastolic and systolic filling of the ventri-
cles; (5) subsequent fall in ejection volume and cardiac output; (6)
absence of orthosympathetic increase in heart rate or total vascular
resistance (TVR). In two other hypotensive patients, two-dimensional
echocardiography showed no change in ejection fraction. The correc-
tion of hypotension was attempted by a bolus injection of 40 ml of 10%
sodium chloride. This procedure abruptly increased plasma osmolality,
reintroduced extravascular fluid into the intravascular space which
resulted in a rise of filling pressures, cardiac output, left stroke work
index (LSWI), and MAP. In group 2, no sudden drop in cardiac output
and LSWI was found despite a similar decrease in filling pressures and
unchanged heart rate and TVR. The absence of orthosympathetic
response observed in both groups was probably multifactorial. The
difference in tolerance to ultrafiltration between the two groups mainly
relied on (1) a difference in ventricular function (2) a difference in
preload and in cardiopulmonary blood volume. Six patients exhibiting
hypotension were treated for 6 months by an injection of 20 ml of 10%
sodium chloride every hour during hemodialysis. Total body sodium did
not change; however, the incidence of hypotension episodes was
reduced significantly. The hemodynamic response to hypertonic saline
depended on extravascular fluid volume. If hypotension occurred
despite hypertonic sodium chloride, the patient was presumed to be
below the ideal weight. This could be restored by giving a plasma
volume substitute. The ideal weight can be considered as the sum of the
patient's weight during a hypotensive episode (not corrected by hyper-
tonic saline) and of the required weight of plasma substitute.
Étude hémodynamique de l'hypotension pendant l'heniodialyse (HD).
Une étude des parametres hémodynamiques a dté réalisée de facon
continue, chez 14 patients pendant une séance d'HD. Huit d'entre eux
(groupe I) ont presenté une diminution brutale de pression artérielle
moyenne (PAM) d'au moms 30 mm Hg alors que les autres (groupe 2)
n'ont diminué leur PAM que de facon progressive. L'analyse de Ia
sequence responsable de l'hypotension présentée par le groupe I est Ia
suivante: (1) hypovolemie induite par l'ultrafiltration (UF); (2) diminu-
tion de I'osmolalité qui aggrave l'hypovolemie par le retard de transfert
des liquides du milieu extravasculaire vers l'espace vasculaire et Ic
passage possible de ces liquides en sens oppose; (3) diminution des
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pressions de remplissage; (4) desequilibre entre les remplissages diasto-
liques et systoliques; (5) diminution consecutive du volume d'éjection
et du debit cardiaque; (6) absence de reaction orthosympatique c'est-à-
dire absence de tachycardie et d'augmentation des resistances vascu-
laires totales (RVT). Chez deux autres patients présentant egalement
une hypotension, aucune variation de Ia fraction d'éjection n'a Pu étre
misc en evidence par des mesures réalisées en echocardiographie bi.
dimensionnelle. L'injection rapide de 40 ml de NaCI 10% entraine une
correction de Ia PAM. En effet, l'augmentation brutale de l'osmolalitC
provoque un transfert de liquide du compartiment extravasculaire vers
le secteur vasculaire avec correction rapide des pressions de remplis-
sage, du DC, de l'index de travail du ventricule gauche (ITVG) et de
PAM. Dans Ic groupe 2, aucune diminution brutale du DC et de l'ITVG
n'a été observée malgré une diminution comparable des pressions de
remplissage, une absence de tachycardie et des RVT inchangées.
L'absence de rCponse orthosympathique observée dans les deux
groupes est probablement multifactorielle. La difference entre les deux
groupes en ce qui concerne La tolerance a l'UF repose principalement
sur: (1) une difference dans Ia fonction ventriculaire (2) une difference
de precharge et de volume sanguin cardiopulmonaire. Six patients
présentant frequemment une hypotension ont été traités pendant 6 mois
par injection pendant I'HD de 20 ml de NaCI 10% toutes les heures. Ces
injections n'ont pas fait varier le sodium total de ces patients mais ont
réduit de manière significative l'incidence des episodes hypotensifs. La
reponse hemodynamique au sodium hypertonique depend de l'impor-
tance du volume liquidien extravasculaire. Si l'hypotension survient
malgré le sodium hypertonique, le patient est en-dessous de son poids
ideal qui ne peut Ctre atteint que par l'infusion d'un substitut plasma.
tique. Le poids ideal peut être estimé en additionnant le poids du patient
enregistré au cours d'un episode hypotensif (non corrige par le sodium
hypertonique) et Ic poids du substitut plasmatique nécessaire a Ia
correction de l'hypotension.
Acute hypotension is a major cause of discomfort in patients
treated by hemodialysis. Its mechanism has been investigated
by several authors. The hemodynamic studies of Bergstrom et
al [1, 2], Wehie et al [3], Hampl et al [4—7], and Rouby et al [8],
compared the tolerance to conventional hemodialysis, sequen-
tial ultrafiltration hemodialysis, hemofiltration, and recirculat-
ing dialysis. Changes in blood osmolality were considered as an
important factor by Bergstrom et a! [1, 2] and Schuenemann et
al [9]. Rouby et al [10, 1 1], and Azancot et al [12] demonstrated
that a delayed plasma refilling rate from the extravascular
spaces may induce severe hypovolemia and hypotension.
While some authors such as Kersh et a! [13] and Chen et al
[14] considered that autonomic neuropathy may be responsible,
other investigators ruled out the eventual role of nervous
system dysfunction [15]. Finally, Hampl et al [5] proposed that
a hyperventilation-related reduction in plasma carbon dioxide
concentration might serve as an etiological factor.
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Table 1. Initial status of patients
Patient
no. Sex
Age
years Diagnosis
Duration of
dialysis
months
Previous
weight gain
g
Residual diuresis
mi/day
First part of the studya
1 M 52 Pyelonephritis 15 1000 500
2 F 39 Glomerulonephritis 77 2500 0
3 F 53 Glomerulonephritis 30 3000 0
4 F 38 Nephroangiosclerosis 43 1100 0
5 M 49 Glomerulonephritis 42 2000 250
6 F 62 Interstitial nephritis 10 1200 1000
7 M 31 Pyelonephritis 6 2000 2000
8 M 49 Glomerulonephritis 2 1100 1500
9 F 39 Pyelonephritis 23 2400 400
10 F 57 Interstitial nephritis 19 1500 0
11 M 53 Nephroangiosclerosis 27 3200 0
12 M 59 Glomerulonephritis 24 800 600
13 F 36 Interstitial nephritis 40 2000 0
14 F 31 Diabetic nephritis 13 2500 1500
Second part of the studyb
15 M 54 Nephroangiosclerosis 53 2200 900
16 F 39 Nephroangiosclerosis 37 1500 0
a The first part of the study is only a hemodynamic investigation.
b The second partis a simultaneous hemodynamic and two-dimensional echocardiographic investigation.
The present study was divided into three sections: (1) an
investigation of the sequence of events before and during
hypotension and after its correction in an attempt to further our
understanding of Why some patients underwent hypotension
during hemodialysis, while others did not; (2) a two-dimension-
al echocardiographic study of two patients as a control of
thermodilution measurement of cardiac output and as a mean
of evaluation of the ejection fraction during hypotension; (3) a
6-month control study of six patients treated systematically
with i.v. hypertonic sodium chloride during hemodialysis.
Methods
In the first part of the study, 14 patients with end-stage renal
failure were investigated by invasive means to evaluate the
hemodynamic parameters during a conventional hemodialysis
session. They were not receiving cardiovascular therapy and
they showed no evidence of cardiac or vascular abnormality.
Their informed consent was obtained using forms approved by
the ethical committee of the University of Liege.
Their clinical status before investigation is summarized in
Table 1. Before the beginning of hemodialysis, a Swan-Ganz
thermodilution catheter (93A13 1-7F) was introduced percutane-
ously using the Seldinger method through a jugular or subclavi-
an vein into a pulmonary artery branch and was left in place for
the whole session. A femoral artery was cannulated by a no. 5
Seldicath for arterial pressure measurements and blood sam-
pling. An invasive measurement of arterial pressure is neces-
sary because it is well known [161 that mean arterial pressure
may be underestimated when measured noninvasively during
major hypotensive episodes. The following parameters were
recorded continuously (H.P. Monitor no. 783421-17402 l-7404A
recorder; Hewlett Packard, Brussels, Belgium): mean arterial
pressure (MAP), right atrial pressure (RAP), mean pulmonary
arterial pressure (MPAP), pulmonary capillary wedge pressure
(PCWP), and heart rate. The cardiac output was measured by
the thermodilution technique (Edwards no. 9520A; Edwards
Laboratories, Santa Ana, California) with an injection of 10 ml
of 5% glucose at 00 C into the right atrium. Cardiac output
measurements were made in triplicate before hemodialysis,
immediately after starting the session, every 30 mm throughout,
and 30 mm after its completion. The cardiac index was calculat-
ed by dividing the cardiac output by the estimated body surface
area and the stroke index (SI) by dividing the cardiac index by
the heart rate.
The left stroke work index (LSWI) in gm2 and the total
vascular resistance (TVR) in dynesseccm5 were calculated
according to the formulas:
LSWI = (MAP — PWP) x SI x 13.6 ÷ (1.000)
TVR = (MAP — RAP) x 80 (CO).
The hemodialysis session was performed with a cuprophan
plate dialyser, 1.0 m2 surface (Gambro® Lund, Sweden) and
lasted 5 hr. The sodium concentration in the dialysate was 140
mmoles/liter. The acetate concentration was 40 mmoles/liter.
Body weight was monitored continuously with an electronic
bed scale. The ultrafiltration flow rate averaged 630 102 mI/hr
and was adjusted for each patient according to his previous
weight gain. At the beginning of the session, 150 ml of blood
was withdrawn to prime the dialyzer. Blood samples (20 ml)
were taken at the moment of each cardiac output recording for
determination of plasma sodium concentration (flame photome-
try), urea concentration (urease applied to Technicon system),
total plasma protein concentration (biuret technique), plasma
osmolality (cryoscopy with Dr. Knauer Halbmikro osmome-
ter), plasma catecholamines concentration [17], and plasma
renin activity [181.
Hypotension was defined as a fall in MAP of at least 30 mm
Hg below the predialysis value. Eight patients (numbered 3, 4,
6, 8, 9, 10, 12, and 14) exhibited such a drop and were placed in
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Table 2. Hemodynamic data of group 1 (8 patients)a
5 mm after 20 mm after
Before
hemodialysis
(1)
starting
hemodialysis
(2)
Acute
hypotension
(3)
10% sodium
chloride
(4)
End of the
session
(5)
Statistical comparison between periods
(1) and (2)(2) and (3)(3) and (4)(2) and (5)
MAP, mm Hg 111.5 7 104.4 6.3 55.1 4.1 79.4 7 83.3 5.2 NS P < 0.001 P < 0.01 P < 0.02
PCWP, mm Hg 9.4 1.6 5.1 1.2 1.9 0.6 4.4 0.9 1.6 0.5 NS P < 0.05 P < 0.05 P < 0.02
RAP, mm Hg 5.7 1.2 3.1 0.9 0.6 0.3 3.1 0.9 1.9 0.9 NS P < 0.05 P < 0.02 NS
HR, beats/mm 78.6 4.9 78.5 4.8 79.5 7.8 77.6 5.7 86.2 5.9 NS NS NS NS
CO, liters/rnin 5.2 0.3 4.6 0.2 3 0.2 4.3 0.2 4.5 0.3 NS P < 0.001 P < 0.01 NS
CI, rnl/minm2 3428 228 3075 193 2022 133 2810 122 2998 252 NS P < 0.001 P < 0.001 NS
SI, ml/systolern2 45 4 40 4 28 4 41 4 33 4 NS P < 0.05 P < 0.05 NS
LSWI, gm/rn2 60.6 4.2 52.6 4.1 19.8 2.8 39.7 3 36.6 1.8 NS P < 0.001 P < 0.001 P < 0.01
TYR, dynesseccm5 1787 144 1895 134 1555 158 1515 122 1556 120 NS NS NS NS
a Values are the mean SEM. The italicized numbers in parentheses refer to the number of periods.
Abbreviations are: MAP, mean arterial pressure; PCWP, pulmonary capillary wedge pressure; RAP, right atrial pressure; HR, heart rate; CO,
cardiac output; CI, cardiac index; SI, systolic inidex; LSWI, left stroke work index; TVR, total vascular resistance; NS, not significant.
group 1. The other six patients (numbered 1, 2,5, 7, 11, and 13)
constituted group 2. Correction of MAP was attempted in each
case by a single bolus injection of 40 ml of 10% sodium chloride
in the venous return of the dialyzer. Hemodynamic data record-
ing and blood sampling were performed again 20 mm after this
injection. The values obtained during acute hypotension in
group 1 were compared with those at 90 mm in group 2 because
all patients in group 1 had demonstrated hypotension by 90 mm.
In a second part of the study, two patients exhibiting frequent
hypotension episodes without any abnormality in segmental
ventricular contraction or valvular heart disease were investi-
gated simultaneously by invasive techniques and echocardiog-
raphy. The status of these two patients is summarized in Table
1. For technical reasons, they were investigated during hemodi-
alysis performed with a Rhodial 75 dialysis system (Hospal
S.A., Brussels, Belgium), using a polyacrylonitrile membrane
dialyzer (RP61O-l m2 area; Hospal S.A., Brussels, Belgium).
The dialyzer was not primed because the volume of the
extracorporeal circuit was 150 ml. The dialysate was as de-
scribed above. Hemodynamic and biological data were collect-
ed as above.
Two-dimensional echocardiographic (2D) imaging was per-
formed in slight left lateral decubitus, simultaneously with a
recording of hemodynamic parameters, cardiac output mea-
surements by thermodilution and blood sampling. The echocar-
diographic data were recorded by a Varian V3000 (Varian
Associates, Palo Alto, California) connected to a videorecorder
(Sanyo Electric Co. Ltd., Osaka, Japan) for 2D imaging. A long
axis view was analyzed, and the outline of the endocardium was
obtained on a rigid transparent support applied on the screen of
the videorecorder planimetered by the use of a HP digitizing
table (HP9874A Digitizer) and a HP computer (HP9828A calcu-
lator; Hewlett Packard, Brussels, Belgium) [19]. The left dia-
stolic and systolic ventricular volumes and the ventricular
stroke volume were calculated by Simpson's rule, taking into
account a magnifying coefficient determined by reference to a
centimetric scale.
The long axis of the ventricle (defined from aorto-mitral
junction to apex) was divided in 100 segments, allowing calcula-
tion of the total volume by the summation of the calculated
volumes in 100 slices.
In the third part of the study, six patients (numbered 3, 4, 6,
8, 12, and 14) who usually exhibited episodes of acute hypoten-
sion during hemodialysis were treated systematically for 6
months with intermittent i.v. injections of sodium chloride
during hemodialysis. Injections of 20 ml of 10% sodium chloride
were given every hour during hemodialysis in the venous return
of the dialyzer. The number of acute hypotensive episodes was
calculated in these six patients for a total of 120 hemodialysis
sessions before and after 6 months of this form of therapy. Total
body sodium was measured by a radioisotopic method before
and 6 months after the initiation of therapy.
The results were expressed as arithmetic means SEM and as
mean differences. Statistical analysis was by Student's (test for
paired or unpaired variables.
Results
First study series. Eight of the 14 patients investigated during
the first part (group 1) exhibited acute hypotension (30 mm
Hg) during the hemodialysis session and six patients (group 2)
did not. The detailed results are presented in Tables 2 and 3.
Mean arterial pressure (Fig. 1). Before hemodialysis, the
MAP was similar in both groups. Five mm after starting
hemodialysis, no statistically significant change in MAP was
observed.
In group 1, maximal hypotension occurred on average 66 1
mm after beginning hemodialysis. The mean ultrafiltration
volume at that time was 610 170 ml. After hypertonic saline
injection, the MAP returned to normal values within 20 mm in
all cases. At the end of the session, the MAP was significantly
lower than initially.
In group 2, a progressive and significant decrease in MAP
was observed during the entire hemodialysis procedure, and
hypotension was not observed although the filtered volume was
the same as in group 1 (720 140 ml).
Cardiac output and calculated left ventricular performance
indexes: cardiac index, systolic index, left stroke work index.
Before the hemodialysis session, cardiac output, cardiac index,
systolic index, and LSWI were significantly higher in group 2
than in group 1 (P < 0.001, P < 0.01, P < 0.05, and P < 0.05,
respectively) (Fig. 1).
In group 1, a significant fall in cardiac output, cardiac index,
systolic index, and LSWI was observed during the hypoten-
sion. These parameters returned to normal values within 20 mm
after hypertonic saline injection. Among the left ventricular
performance indexes, only the decrease in LSWI reached a
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Table 3. Hemodynamic data of group 2 (6 patients)
5 mm after
Before
hemodialysis
(1)
starting
hemodialysis
(2) 90 mm (3)
End of the
session (4)
Statistical comparison between periods
(1) and (2) (2) and (3) (2) and (4)
MAP, mm Hg 117.7 3.4 111 1.9 98 4.5 93.3 4.8 NS P < 0.05 P < 0.01
PCWP, mm Hg 16.3 1.6 13.2 2.6 7.7 1.8 5.2 1.7 NS NS P < 0.05
RAP, mm Hg 5,2 1 4.3 0.6 1 0.6 0 0.9 NS P < 0.01 P < 0.01
HR, beats/mm 81.5 5.8 82 6.5 88.8 6.5 90.7 17.2 NS NS NS
CO. liters/mm 7.5 0.3 7.4 0.3 7.7 0.3 6.6 0.2 NS NS P < 0.05
CI, ml/minm2 4578 211 4452 214 4613 133 4112 273 NS NS NS
SI, ml/systo1e,n2 56.9 2.2 58.4 2.8 56.8 3.3 51 1.6 NS NS P < 0.05
LSWI, gm2 74 3.6 73.3 5.3 61.2 3.6 51.4 6.6 NS NS P < 0.05
TVR,dynesseccm5 1142 49 1136 51 1090 61 1118 88 NS NS NS
Values are the means SEM. Abbreviations are defined in Table 2. Italicized numbers in parentheses refer to the number of the period.
Fig. 1. Comparison of hemodynamic
parameters in both groups of patients
during hemodialysis. Abbreviations are:
MAP, mean arterial pressure; CO,
cardiac output; SI, systolic index;
TVR, total vascular resistance; HR,
heart rate. Group 1 is formed by eight
patients exhibiting a hypotension during
hemodialysis (HD). Correction of
hypotension was achieved by injection
of 40 ml 10% sodium chloride (vertical
arrow). Group 2 is formed by the six
other patients. Superscripts, one
asterisk and two asterisks, denote
values that were significantly different
from values of the previous period: P <
0.05; P < 0.001, respectively.
level of statistical significance at the end of hemodialysis. In
group 2, cardiac output, cardiac index, systolic index, and
LSWI decreased together with MAP during the entire
procedure.
Ventricular filling pressures: right atrial pressure, pulmo-
nary capillary wedge pressure (Fig. 2). The values for RAP
before hemodialysis did not differ among the two groups;
however, PCWP was significantly higher in group 2 (P < 0.02).
After 5 mm of hemodialysis, a significant decrease was not
observed in either group.
In group 1, a progressive decrease in filling pressures was
observed from the beginning of hemodialysis to the time of
hypotension. After saline injection, PCWP and RAP returned to
their initial values and then decreased continuously until the
end of hemodialysis.
In group 2, the filling pressures decreased progressively
during the entire procedure without hypotension. At 90 mm, the
Group 2j
I I
Before Start of 90 mm End of
HO HO HD
reduction in RAP and PCWP were equal to those observed in
group 1 at the time of hypotension.
Total vascular resistance (Fig. 1). Before hemodialysis the
TVR values were higher in group 1 than in group 2 (P < 0.02).
In group 1, a slight rise in TVR was observed 5 mm after
starting hemodialysis; it did not vary significantly during subse-
quent hypotension, correction of the latter, or the remainder of
hemodialysis. In group 2, TVR was constant during the entire
procedure.
Heart rate (Fig. 1). In both groups, the heart rate was similar
prior to hemodialysis with no statistically significant variation
observed during the procedure, even in group 1 during the
hypotension episodes.
Blood chemistry. Before hemodialysis, no significant differ-
ence between both groups was observed in plasma sodium
concentration, plasma protein concentration, hematocrit, urea
concentration, and osmolality or catecholamine concentration.
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Fig. 2. Comparison of hemodynamic
and chemical parameters in both
groups of patients during hemodialysis.
Abbreviations are: MAP, mean arterial
pressure; RAP, right atrial pressure;
PCWP, pulmonary capillary wedge
pressure; PP, plasma proteins
concentration; OSM, plasma
osmolality. Group 1 is formed by eight
patients exhibiting a hypotension during
hemodialysis (HD). Correction of
hypotension was achieved by injection
of 40 ml 10% sodium chloride (vertical
arrow). Group 2 is formed by the six
other patients. Superscripts, one
asterisk and two asterisks, denote
values that were significantly different
from values of the previous period: P <
0.05; P < 0.001, respectively.
Plasma renin activity (PRA) was significantly higher in group I
before and during hemodialysis (P < 0.05). In group 1, at the
time of hypotension the rise in plasma protein concentration
and the fall in osmolality were significant (P < 0.05 and P <
0.01). Twenty mm after a saline injection, a significant decrease
in plasma protein concentration (P < 0.05) was evidenced
without variation in osmolality or plasma sodium concentra-
tion. During the remainder of hemodialysis, plasma protein
concentration increased again (P < 0.02), but no subsequent
decrease in osmolality was observed.
To evaluate the changes in osmolality more accurately,
plasma protein concentration and hematocrit during saline
injection, sequential blood samplings were made every 10 sec
after a 40 ml injection of 10% saline. To avoid bias in the
hemodynamic measurements due to blood withdrawal and
volume loss, the measurements were made separately in ten
patients under the same conditions of hemodialysis. Shortly
after the saline injection an abrupt rise in osmolality was
observed. A peak value of 330 mOsm/kg was reached and lasted
approximately 2 mm. Osmolality, plasma protein concentra-
tion, and hematocrit then decreased. Osmolality returned to
previous values 20 mm after the injection.
In group 2, plasma protein concentration and hematocrit
increased (P < 0.001 and P < 0.05) during the entire procedure
while plasma urea concentration and osmolality decreased (P <
0.01 and P < 0.02). The total decrease in osmolality was not
statistically different between the two groups.
Variations in plasma catecholamine concentration or PRA
were not observed in either group.
Ventricular function curves (Figs. 3 and 4). The variations of
PCWP and LSWI allowed the drawing of a ventricular function
curve. In Figure 3, only the points of ventricular function at the
start of hemodialysis, during hypotension in group 1 and at 90
mm in group 2 have been plotted. The angular coefficient of the
curves is significantly higher in group 1 than in group 2 (group 1:
4.2 1.1; group 2: 0.26 0.1;P < 0.02). The points of function
of three patients representative of group 1 are shown in Figure 4
at the start of hemodialysis, during hypotension, and after its
correction by sodium chloride. The major fall of LSWI is
evident when associated with the decrease in PCWP and the
complete correction of both values after an injection of hyper-
tonic saline.
Second study series. In both patients, the hemodynamic
values were similar to those observed in group 1 during the first
phase. Left ventricular stroke volume (LVSV) calculated by
two-dimensional echocardiography (2D) correlated closely with
corresponding values obtained by thermodilution (r = 0.97).
The evolution of changes of MAP, cardiac output, left ventricu-
lar end diastolic volume (LVEDV), left ventricular end systolic
volume (LVESV), left ventricular stroke volume, and left
ventricular ejection fraction (EF) are shown in Figure 5 for
patient no. 15. Prior to hypotension, a progressive decrease in
LVEDV, LVESV, LVSV, cardiac output, cardiac index, and
filling pressures were observed. During the presence of acute
hypotension, the LVESV was minimal and a further reduction
of LVEDV resulted in a decrease of LVSV and calculated
cardiac output, without an increase in heart rate. At that time, a
paradoxical bradycardia in patient no. 15, a slight tachycardia in
patient no. 16, and a slight fall in the TVR in both, were noted.
The injection of hypertonic saline was followed by an increase
in LVEDV, LVSV, cardiac output, cardiac index, systolic
index, LSWI, filling pressures, TVR, and MAP. The EF
remained nearly constant throughout the whole session. The
blood chemistry values of the two patients closely followed
those found in group 1.
Third study series. Before initiation of the treatment, 132
Before
HD
Group 2
______________
Start of
HD
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Fig. 3. Ventricular function in both groups. The ventricular function,
according to Starling's diagram, is appreciated by the relationship
between left stroke work index (LS WI) and pulmonary capillary wedge
pressure (PCWP). Group 1 (patients numbered 3, 4, 6, 8, 9, 10, 12, and
14) exhibiting a hypotension during hemodialysis. Group 2 (patients
numbered 1, 2, 5, 7, 11, and 13) showed no hypotension during
hemodialysis. Symbols are: (0), figure the start of HD and (I), the
moment of hypotension in patients of group 1 (—) and 90 mm after the
start of hemodialysis in patients of group 2 ( ).
hypotension episodes were observed on a total of 120 hemodial-
ysis sessions. Under therapy, only 59 hypotensive episodes
were noted in the same number of sessions. This reduction is
significant when analysed by x2 (P < 0.001). The mean total
exchangeable sodium before treatment was 51.5 4 mEq/kg.
No statistically significant variation was observed after 6
months of prevention because the end mean total exchangeable
sodium was 51.8 5.7 mEq/kg.
Discussion
This study's results demonstrate that acute hypotension
experienced by group 1 patients depended on the following
sequence of events: ultrafiltration-induced hypovolemia, a de-
crease in the venous return to the heart, a decrease in filling
pressures and in cardiac output, cardiac index, systolic index,
and LSWI without orthosympathetic response (that is, without
increase in heart rate and TVR). Moreover, hemodialysis led to
a decrease in plasma osmolality. The latter then delayed the
transfer of fluid from an extravascular to a vascular compart-
ment and probably produced a shift of fluid in the opposite
direction thus aggravating the decrease in filling pressures. This
induced a sudden drop in cardiac output and hypotension. Our
experience suggested that the decrease in osmolality is a major
component in the explanation of the mechanism of hypoten-
sion. Indeed, it was noticed that a correction of hypotension in
all group 1 patients after the injection of hypertonic saline with
the resultant abrupt increased plasma osmolality induced a
reintroduction of extravascular fluid into the intravascular
space. This was demonstrated by the fall in total plasma protein
concentration and the simultaneous increase in filling pressures
subsequent to the injection. This latter corrected cardiac output
and mean arterial pressure without variation in heart rate or
total vascular resistance. The difference in tolerance to ultrafil-
tration between the two groups of patients depended mainly on
a difference in preload and cardiac performance as shown by
the ventricular function curves according to Starling's law: (1)
preload determines the position of the function point at the start
of ultrafiltration. The more the initial function point is displaced
up and to the right, the better the tolerance will be. This higher
preload can depend on the total blood volume. So, the mean
values of PRA were significantly higher in group 1 than group 2
and could suggest that there was a greater fluid depletion in
group 1 [20]. In fact, the absence of a significant correlation
between individual plasma renin activity and filling pressures is
not compatible with this interpretation. However, for the same
total blood volume, the distribution between peripheral and the
central blood volume may be different, thereby influencing the
preload and the filling pressures. The difference in repartition of
fluid could explain the difference in both groups. Hormonal
influence as such as that caused by vasopressin could play a
80
013 -
5TJIiII12
—
80
60
E
40
20
I—
5 10
PCWP, mm Hg
15
5 10
PCWP,mm Hg
Fig. 4. Parallelism ofventricularfunction response during intravascular
fluid depletion and filling (after hypertonic saline) in three patients
exhibiting hypotension during hemodialysis. Symbols are: (0). figure
the start of hemodialysis; (I), the moment of hypotension; (A) 90 mm
after hypertonic sodium chloride bolus injection.
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Fig. 5. Hemodynamic and echocardiographic data during hemodialysis
in a patient no. 15 exhibiting a hypotension. Abbreviations are: MAP,
mean arterial pressure; CI, cardiac index; LVEDV, left ventricular and
diastolic volume; LVESV, left ventricular and systolic volume; LVSV,
left ventricular stroke volume; HR, heart rate; EF, left ventricular
ejection fraction.
role in this difference [2 1—241. (2) Group 2 had a higher preload
and could in fact have their point of ventricular function on the
horizontal part of a similar Starling's curve. With a higher
ultrafiltration rate, the pulmonary capillary wedge pressure of
group 2 could have been lowered more, resulting in the same
LSWI reduction as in group 1. Nevertheless, all patients do not
demonstrate similar curves. For instance, patients numbered 7
and 13 have high LSWI for the pulmonary capillary wedge
pressure of zero and 5 mm Hg, respectively, and the horizontal
part of their Starling's curve is located more to the left than
others. This intrinsic difference in cardiac performance results
in a better tolerance to ultrafiltration.
In the second study series, the 2D echocardiographic mea-
surements showed that the decrease in filling pressures induced
a reduction in left ventricular end diastolic volume and in left
ventricular stroke volume. This confirms the decrease in systol-
ic index observed in the first phase of the study. A variation in
ejection fraction was not observed since left ventricular end
diastolic volume decreased simultaneously with left ventricular
stroke volume. The 2D echocardiographic measurements were
very well correlated with the thermodilution measurements. (It
was important to control these thermodilution measurements
because the patient was placed in an extravascular circuit with a
possible variation of temperature.)
Our data confirm some previous observations made by others
[1—12, 25—261. Although the osmolality [1—3, 8—10] or delayed
plasma refilling rate [11] have been considered the most impor-
tant factors influencing hypotension, our results have demon-
strated the major influence of osmolality variations on the filling
pressures and the subsequent sequence of events inducing
hypotension. Moreover, we have shown the possibility of
correction of hypotension by injecting small amounts of hyper-
tonic saline intermittently and have also approached the prob-
lem of difference in tolerance to the effects of ultrafiltration.
Uremic neuropathy has been thought very often to be a major
factor involved in hypotension [13—15, 27—341. This uremic
neuropathy can certainly impair the orthosympathetic re-
sponse, suppress a compensatory mechanism, and lead to the
occurrence of hypotension. However, in our series of patients
uremic neuropathy cannot be the only cause of the absence of
orthosympathetic response. Indeed, this absence (that is, ab-
sence of increase in TVR and heart rate) was observed in both
groups. On the other hand, several patients investigated in this
study underwent further hemodynamic measurements during
other dialysis procedures (hemofiltration, sequential ultrafiltra-
tion) and showed an increase in heart rate and TVR. These
preliminary results demonstrate that an orthosympathetic re-
sponse can occur in these patients under other conditions of
dialysis. We have no logical explanations for this specific
absence of response during hemodialysis and not during the
other procedures. Slight alkalosis [35], biocompatibility of the
membrane and acetate in the dialysate could be some of the
various factors influencing our understanding of this phenome-
non. The role of acetate usually is related to a vasodilation
depending on the different susceptibility of patients [36—391. If
acetate plays a role in the occurrence of hypotension, it alone is
insufficient to explain the difference in our two groups of
patients. Indeed, the total vascular resistance values in group 2
remained constant during hemodialysis and were always lower
than the total vascular resistance values in group 1. The uremic
cardiomyopathy is also one of the numerous factors suspected
by others [40—44] which can influence hypotension. The high
levels of ventricular function curves in all patients and the
invariate ejection fraction during hemodialysis in two patients
excluded the principal role of this factor in our series of
patients.
Several other factors should be further studied to improve
understanding of these phenomena. The respective effects of
arterial and especially venous compliance should be considered
although this approach was extremely difficult in this study.
The possible role of the fistula on the preload and the ventricu-
lar function curve should also not be ignored. No measurements
of blood viscosity were performed, thus we were unable to
determine the specific influence of viscosity changes on the
maintenance of arterial pressure. However, this does not seem
to be responsible for the difference in tolerance because its two
main determinants, hematocrit and total plasma protein concen-
tration, were similar in both groups. Because the reduction in
osmolality is the same in both groups, a greater fluid extravasa-
tion causing hypotension in group 1 may not be relevant.
Nevertheless, a difference in capillary permeability could exist
but was not investigated in this study. Finally, an eventual
hypervagotonism could perhaps explain the paradoxical brady-
cardia sometimes observed during hemodialysis.
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In the third study series, the systematic i.v. injection of 20 ml
of 10% hypertonic saline every hour reduced the frequency of
hypotension in sensitive patients. This preventive procedure
did not completely suppress the occurrence of hypotension, but
a closer analysis of the results shows that four of the six patients
endured no subsequent hypotension episodes. These 59 epi-
sodes were observed in two patients which were below their
ideal weight as demonstrated by hemodynamic records (pulmo-
nary capillary wedge pressure equals 0 mm Hg at the beginning
of the session).
The correction and prevention of hypotension by hypertonic
saline demonstrates the existence of an extravascular fluid store
easily returned to the intravascular space by increasing plasma
osmolality. If the hypertonic saline injection does not correct
the hypotension, one can speculate that the extravascular fluid
is not in excess. The patient is presumably below his ideal
weight and an infusion of plasma substitute is necessary to
restore arterial pressure. The patient then reaches his or her
ideal weight and ultrafiltration must be stopped. This approach
provides an easy estimation of the ideal weight. It can be
considered as the sum of the patient's weight at the time of a
hypotensive episode not corrected by an i.v. bolus of hyperton-
ic saline and the plasma substitute weight required to restore
arterial pressure. Three points relevant to the estimation of
ideal weight are worth mentioning in light of our experience: (1)
If the patient becomes thirsty, the doses of hypertonic saline
may be decreased. Indeed, this occurs in patients (commencing
hemodialysis with high level osmolality) exhibiting hypotension
despite absolute levels of osmolality higher than other patients.
(2) If the patient reaches his or her ideal weight according to the
formula and exhibits frequent }iypotension episodes, despite no
subsequent ultrafiltration and hypertonic saline injection, this
hypotension is considered to be related principally to vasodila-
tion. In this unusual situation dialysis with bicarbonate or other
procedures (hemofiltration or sequential ultrafiltration) could
be used with a good chance of success. We have experienced
only one unsuccessful case. In that patient, uremic neuropathy
(as demonstrated by electromyography) was a major problem
and the three usual hemodialysis sessions per week were
replaced by two hemodialysis sessions followed by one plasma-
pheresis session. This patient actually did not exhibit hypoten-
sion and his neuropathy was resolved completely. (3) The
systematic use of hypertonic saline is relatively contraindicated
in patients presenting with a decreased ejection fraction.
In summary, this hemodynamic study has allowed a better
understanding of the mechanism oc hemodialysis-induced hypo-
tension to be made and has enabled a method to correct and
prevent its occurrence to be developed. It has also provided a
simple approach to the estimation of ideal weight.
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